Access to Medicines
It is critical that high-quality, effective medicines are available to those who need them most. We are working with patient-centered programs in two key areas, firstly for tuberculosis (now the leading global infectious killer of adults) and secondly for opioid overdose (the leading cause of accidental death in US). Details below.
Drug Access Mapping
AA&D is working to build useful digital tools that map gaps around TB medicines, as well as naloxone, a life-saving opioid overdose reversal drug.
The TB Drug Access Atlas, which is slated for release in late Quarter 2 of 2017, focuses on Internationally Assured Second-Line Drugs (medicine to treat drug-resistant TB). It is a data-driven tool built with the goal to help inform decision-making, reduce programmatic redundancy where appropriate, take advantage of shared strengths, and address clear gaps in the areas of intervention where needed.